A1300 Vitamin K2 (as Menaquinone-7) as a permitted form of Vitamin K in FSMP

Overview

FSANZ has assessed an application made by Novozymes Australia Ltd. to amend the Australia New Zealand Food Standards Code to permit the use of Vitamin K2 (as Menaquinone-7) as a permitted form of Vitamin K in food for special medical purposes (FSMP). FSANZ has prepared a draft food regulatory measure. 

FSANZ has provided public notification and welcomes your submission to assist with consideration of the application.

Consultation papers

The consultation documents and a copy of the application are provided below. Please read these documents before preparing your submission. 

• Call for submissions report (PDF 394KB).
• Supporting document 1 - risk and technical assessment  (PDF 608KB).
• Application - from the applicant (PDF 2MB).

You can find further information on A1300 on the FSANZ website. 

Why your views matter

FSANZ invites and welcomes public and stakeholder input into standard setting processes. Your views will help us ensure food standards continue to protect public health and safety while supporting an effective, transparent and accountable regulatory framework for industry and food authorities.

How to make a submission

The Consultation Hub is FSANZ's platform for public consultation. We have set up an online survey response form to assist you in completing your submission. Please refer to the consultation documents in preparing your submission. Once you begin, you can save your progress and complete your submission before the consultation closes on 11 October 2024 at 6pm Australian Eastern Standard Time (AEST).

What happens next

Consultation on A1300 - Vitamin K2 (as Menaquinone-7) as a permitted form of Vitamin K in FSMP has closed. Submissions received will now be considered as part of the assessment process.